The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression and is accelerating clinical trials with new capital.

CEO Steven Gourlay, joins The Market Online to discuss the company’s development.

Join the discussion: See what HotCopper users are saying about Actinogen Medical Ltd and be part of the conversations that move the markets.

acw by the numbers
More From The Market Online

Lightning Minerals ramps up AI exploration plans in WA

Lightning Minerals will target its WA gold projects with input from advanced AI exploration specialist Eigenform…
CGT changes concept

Week 28, Wrapped: ETF fever takes over ASX; CGT changes hit property market & more

Welcome to another HotCopper weekly wrap by yours truly – have you missed me!? – if I had to pick one big takeaway

Krakatoa Resources sights visual antimony at Zopkhito in drilling highlights

Krakatoa Resources has made multiple antimony sightings in early stages of drilling at the Zopkhito project,…

Great Northern Minerals defines new IP targets at Iron Butte gold-silver project

Great Northern Minerals has identified a number of new targets at the Iron Butte gold–silver project…